Crispr Therapeutics AG is trading at $51.65 (+4.5%) in pre-market as the stock rebounds from yesterday's decline amid improved risk sentiment for biotech and growth stocks.
- The recovery follows a 3.96% drop in the previous session and a period of sharp price swings observed last week.
- There are no company-specific headlines or regulatory filings overnight; the move appears to be tracking stronger index futures.